All‐oral direct‐acting antiviral therapy against hepatitis C virus (HCV) in human immunodeficiency virus/HCV–coinfected subjects in real‐world practice: Madrid coinfection registry findings

• Published in: Hepatology (Baltimore, Md.) Vol. 68; no. 1; pp. 32 - 47
• Main Authors: Berenguer, Juan, Gil‐Martin, Ángela, Jarrin, Inmaculada, Moreno, Ana, Dominguez, Lourdes, Montes, Marisa, Aldámiz‐Echevarría, Teresa, Téllez, María J., Santos, Ignacio, Benitez, Laura, Sanz, José, Ryan, Pablo, Gaspar, Gabriel, Alvarez, Beatriz, Losa, Juan E., Torres‐Perea, Rafael, Barros, Carlos, Martin, Juan V. San, Arponen, Sari, de Guzmán, María T., Monsalvo, Raquel, Vegas, Ana, Garcia‐Benayas, María T., Serrano, Regino, Gotuzzo, Luis, Menendez, María Antonia, Belda, Luis M, Malmierca, Eduardo, Calvo, María J., Cruz‐Martos, Encarnación, González‐García, Juan J.
• Format: Journal Article
• Language: English
• Published: United States Wolters Kluwer Health, Inc 01.07.2018; John Wiley and Sons Inc
• Subjects: Administration, Oral; Antiviral agents; Antiviral Agents - therapeutic use; Antiviral drugs; CD4 antigen; Cirrhosis; Coinfection; Confidence intervals; Female; Genotypes; Health risk assessment; Hepacivirus - genetics; Hepatitis; Hepatitis C; Hepatitis C - complications; Hepatitis C - drug therapy; Hepatology; HIV; HIV Infections - complications; Human immunodeficiency virus; Humans; Immunosuppression; Interferon; Liver cirrhosis; Liver Cirrhosis - complications; Liver diseases; Lymphocytes T; Male; Middle Aged; Motivation; Original; Patients; Registries; Ribavirin; Ribonucleic acid; Ritonavir; RNA; RNA viruses; Sex ratio; Treatment Failure

We evaluated treatment outcomes in a prospective registry of human immunodeficiency virus/hepatitis C virus (HCV)–coinfected patients treated with interferon‐free direct‐acting antiviral agent–based therapy in hospitals from the region of Madrid between November 2014 and August 2016. We assessed sus...